Literature DB >> 6688181

Aryl hydrocarbon hydroxylase activity and psoriasis.

M J Finnen, S Shuster, C M Lawrence, M D Rawlins.   

Abstract

Aryl hydrocarbon hydroxylase (AHH) has been measured in the skin, jejunum and liver of normal and psoriatic individuals. We have been unable to confirm previous reports of an abnormality in AHH activity in patients with psoriasis. Re-examination of the laboratory records on which the original reports were based leads us to doubt their veracity and validity.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6688181     DOI： 10.1016/0006-2952(83)90113-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


  6 in total

1.  Antipyrine clearance and metabolism in patients with psoriasis.

Authors:  K Kubota; T Ishizaki; K Chiba; A Takagi; A Nakagawa; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

2.  Determination of cytochrome P-448 activity in biological tissues.

Authors:  C E Phillipson; P M Godden; P Y Lum; C Ioannides; D V Parke
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

3.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

4.  Reduction of antipyrine clearance in psoriasis.

Authors:  J R Marsden; F M Williams; B Keys; M D Rawlins; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

5.  Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.

Authors:  G Mason; M D Rawlins; S Shuster
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

6.  Human epidermal blister: a convenient tissue for toxicological and genetic studies of benzo(a)pyrene metabolism.

Authors:  J Van Cantfort; T Lorand; J E Gielen; C M Lapière
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.